🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Leslie Popplewell

City Of Hope National Medical Center

ORCID: 0000-0002-8418-2811

Also affiliated with City of Hope

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE”.

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423
N/A
3.0DataRank · unranked
121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

The Lancet Haematology(2022)10.1016/s2352-3026(22)00318-0
N/A
1.4DataRank · unranked
41 citations

Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei +20 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485
N/A
1.3DataRank · unranked
40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021004981
N/A
0.733DataRank · unranked
13 citations

Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus Poku, James R. Bading +23 more

Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study

The Lancet Haematology(2024)10.1016/s2352-3026(24)00171-6
N/A
0.673DataRank · unranked
20 citations

Jasmine Zain, Kerry J. Savage, Tatyana Feldman, Jonathan E. Brammer, Lu Chen +14 more

Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma

Haematologica(2023)10.3324/haematol.2023.283002
N/A
0.599DataRank · unranked
19 citations

Matthew Mei, Lu Chen, Joo Y. Song, Victoria Bedell, Elizabeth Budde +13 more

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371
N/A
0.494DataRank · unranked
7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309.v1
N/A
0DataRank · unranked
0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0236
N/A
0DataRank · unranked
46 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009890
N/A
0DataRank · unranked
14 citations

Matthew J. Frigault, Michael Heim, S.R. Foley, Brian T. Hill, Grant Schofield +14 more

Gene Therapy: Charting a Future Course—Summary of a National Institutes of Health Workshop, April 12, 2013

UNC Libraries(2020)10.17615/bazj-3394
N/A
0DataRank · unranked
0 citations

Howard J. Federoff, Luk H. Vandenberghe, Aravind Asokan, Mehrdad Abedi, Laurie Zoloth +27 more

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2378
N/A
0DataRank · unranked
43 citations

Anamarija M. Perry, Alex F. Herrera, Lu Chen, Pamela Skrabek, Michel R. Nasr +19 more

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

Hematological Oncology(2021)10.1002/hon.178_2880
N/A
0DataRank · unranked
1 citations

Michael Dickinson, Joaquín Martínez‐López, Arne Kolstad, Stephen J. Schuster, Martin Dreyling +29 more

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

American Journal of Hematology(2023)10.1002/ajh.27069
N/A
0DataRank · unranked
34 citations

Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H. Baird +13 more

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7100
N/A
0DataRank · unranked
12 citations

Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh +17 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309
N/A
0DataRank · unranked
0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more